// App-Quantinova.ai

2544 : SER-ONCOVID: Seroconversion in solid-tumor cancer patients after COVID-19 diagnosis.

Researchers

Presenter

  • Anna Pous

Principal Investigators

  • Eudald Felip

  • Olatz Etxaniz

  • Ainhoa Hernandez Gonzalez

  • Sofia Espaa

  • Margarita Romeo

  • David James Pinato

  • Anna Esteve

  • Ricard Mesia

Medical Centers

  • ICO Badalona, Barcelona, Spain

  • Medical Oncology Department, Germans Trias i Pujol Hospital, Catalan Institute of Oncology (ICO), Badalona, Spain

  • Medical Oncology. Institut Català d'Oncologia (ICO) Hospital Germans Trias i Pujol, Badalona, Spain

  • Institut Catala d'Oncologia Badalona. Applied Research Group in Oncology (B- ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain

  • Medical Oncology Department, Institut Catala dOncologia (ICO) Badalona, B-ARGO, Badalona, Spain

  • Institut Catala d'Oncologia Badalona-H U Germans Trias i Pujol, Badalona, Spain

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

  • Cancer Statistics Department, Catalan Institute of Oncology-Hospital Germans Trias i Pujol, Badalona, Spain

  • Catalan Institute of Oncology, IDIBELL, Barcelona, Spain

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Coronavirus disease

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved